These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 567372)

  • 1. Phenylalanine depletion for the management of phenylketonuria: use of enzyme reactors with immobilized enzymes.
    Ambrus CM; Ambrus JL; Horvath C; Pedersen H; Sharma S; Kant C; Mirand E; Guthrie R; Paul T
    Science; 1978 Sep; 201(4358):837-9. PubMed ID: 567372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of phenylalanine in the blood of phenylketonuric patients using a PAL-enzyme reactor. An in vitro study.
    Ambrus CM; Horváth C; Kalghatgi K; Clowsley M; Huzella C; Warner R; Ambrus JL; Cooley CM; Mirand EA
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):105-11. PubMed ID: 7122995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria.
    Ambrus CM; Anthone S; Horvath C; Kalghatgi K; Lele AS; Eapen G; Ambrus JL; Ryan AJ; Li P
    Ann Intern Med; 1987 Apr; 106(4):531-7. PubMed ID: 3826953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L; Chang TM
    Biochim Biophys Acta; 1986 Oct; 883(3):432-8. PubMed ID: 3756210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria.
    Bourget L; Chang TM
    FEBS Lett; 1985 Jan; 180(1):5-8. PubMed ID: 4038490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An extracorporeal hollow-fiber reactor for phenylketonuria using immobilized phenylalanine ammonia lyase.
    Larue C; Munnich A; Charpentier C; Saudubray JM; Frézal J; Rémy MH; Rivat C
    Dev Pharmacol Ther; 1986; 9(2):73-81. PubMed ID: 3956347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitubular reactors with immobilized L-phenylalanine ammonia-lyase for use in extracorporeal shunts.
    Kalghatgi K; Horváth C; Ambrus CM
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):551-61. PubMed ID: 7384643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of immobilized L-phenylalanine ammonia-lyase in tubular form for depletion of L-phenylalanine.
    Pedersen H; Horvath C; Ambrus CM
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):559-69. PubMed ID: 674832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of phenylalanine ammonia-lyase.
    Roberts J; Schmid FA; Takai K
    Cancer Treat Rep; 1976 Mar; 60(3):261-3. PubMed ID: 1260781
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic control of phenylalanine intake in phenylketonuria.
    Hoskins JA; Jack G; Wade HE; Peiris RJ; Wright EC; Starr DJ; Stern J
    Lancet; 1980 Feb; 1(8165):392-4. PubMed ID: 6101846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entrapment of phenylalanine ammonia-lyase in silk fibroin for protection from proteolytic attack.
    Inoue S; Matsunaga Y; Iwane H; Sotomura M; Nose T
    Biochem Biophys Res Commun; 1986 Nov; 141(1):165-70. PubMed ID: 3800993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylalanine ammonia lyase in the management of phenylketonuria: the relationship between ingested cinnamate and urinary hippurate in humans.
    Hoskins JA; Gray J
    Res Commun Chem Pathol Pharmacol; 1982 Feb; 35(2):275-82. PubMed ID: 7071414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral administration of artificial cells immobilized phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats.
    Bourget L; Chang TM
    Biomater Artif Cells Artif Organs; 1989; 17(2):161-81. PubMed ID: 2775877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria.
    Wang L; Gamez A; Sarkissian CN; Straub M; Patch MG; Han GW; Striepeke S; Fitzpatrick P; Scriver CR; Stevens RC
    Mol Genet Metab; 2005; 86(1-2):134-40. PubMed ID: 16006165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of phenylalanine ammonia lyase as an intracellularly free and extracellularly cell surface-immobilized enzyme on a gut microbe as a live biotherapeutic for phenylketonuria.
    Jiang Y; Sun B; Qian F; Dong F; Xu C; Zhong W; Huang R; Zhai Q; Jiang Y; Yang S
    Sci China Life Sci; 2023 Jan; 66(1):127-136. PubMed ID: 35907113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
    Goldfinger M; Zeile WL; Corado CR; O'Neill CA; Tsuruda LS; Laipis PJ; Cooper JD
    Mol Genet Metab; 2017 Sep; 122(1-2):33-35. PubMed ID: 28506393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria.
    Levy HL; Sarkissian CN; Scriver CR
    Mol Genet Metab; 2018 Aug; 124(4):223-229. PubMed ID: 29941359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria.
    Chang TM; Bourget L; Lister C
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(1):1-21. PubMed ID: 7719440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylketonuria: old disease, new approach to treatment.
    Levy HL
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1811-3. PubMed ID: 10051548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.